Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaurav Syal

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
The American Journal of Gastroenterology|October 28, 2024
Medical Therapies for Prevention and Treatment of Inflammatory Pouch Disorders-A Systematic Review and Meta-AnalysisGaurav Syal, Edward Barnes, Laura Raffals, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 12, 2024
No Impact of Concomitant Medications on Efficacy and Safety of Biologics and Small Molecules for Ulcerative ColitisDhruv Ahuja, Guangyong Zou, Virginia Solitano, et al.
Physiological Reports|November 22, 2014
MCP-1 downregulates MMP-9 export via vesicular redistribution to lysosomes in rat portal fibroblastsDaShawn A Hickman, Gaurav Syal, Michel Fausther, et al.
Alimentary Pharmacology & Therapeutics|December 11, 2024
Long-Term Outcomes of an Infliximab-First Versus Vedolizumab-First Treatment Strategy in Biologic-Naïve Patients With Ulcerative ColitisAustin Haynesworth, Kuan-Hung Yeh, Han Hee Lee, et al.
Inflammatory Bowel Diseases|October 28, 2023
Effectiveness of Oral Tofacitinib in Chronic Pouchitis: A Prospective, Open-Label Pilot StudyGaurav Syal, Daniel S Mishkin, Andrea Banty, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 12, 2024
Impact of Treatment Response on Risk of Serious Infections in Patients With Crohn's Disease: Secondary Analysis of the PYRAMID RegistryDhruv Ahuja, Jiyu Luo, Yuchen Qi, et al.
Digestive Diseases and Sciences|March 15, 2020
Hypoalbuminemia and Bandemia Predict Failure of Infliximab Rescue Therapy in Acute Severe Ulcerative ColitisGaurav Syal, Lori Robbins, Amir Kashani, et al.
The American Journal of Gastroenterology|March 12, 2025
IL-23p19 Antagonists vs Ustekinumab for Treatment of Crohn's Disease: A Meta-Analysis of Randomized Controlled TrialsClaudia Dziegielewski, Yuhong Yuan, Christopher Ma, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 28, 2024
Differential Efficacy of Advanced Therapies in Inducing Remission in Ulcerative Colitis Based on Prior Exposure to TNF AntagonistsHan Hee Lee, Virginia Solitano, Sujay Singh, et al.
Gastroenterology|November 22, 2025
AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn's DiseaseFrank I Scott, Ashwin N Ananthakrishnan, Benjamin Click, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
The American Journal of Gastroenterology|October 28, 2024
Medical Therapies for Prevention and Treatment of Inflammatory Pouch Disorders-A Systematic Review and Meta-AnalysisGaurav Syal, Edward Barnes, Laura Raffals, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 12, 2024
No Impact of Concomitant Medications on Efficacy and Safety of Biologics and Small Molecules for Ulcerative ColitisDhruv Ahuja, Guangyong Zou, Virginia Solitano, et al.
Physiological Reports|November 22, 2014
MCP-1 downregulates MMP-9 export via vesicular redistribution to lysosomes in rat portal fibroblastsDaShawn A Hickman, Gaurav Syal, Michel Fausther, et al.
Alimentary Pharmacology & Therapeutics|December 11, 2024
Long-Term Outcomes of an Infliximab-First Versus Vedolizumab-First Treatment Strategy in Biologic-Naïve Patients With Ulcerative ColitisAustin Haynesworth, Kuan-Hung Yeh, Han Hee Lee, et al.
Inflammatory Bowel Diseases|October 28, 2023
Effectiveness of Oral Tofacitinib in Chronic Pouchitis: A Prospective, Open-Label Pilot StudyGaurav Syal, Daniel S Mishkin, Andrea Banty, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 12, 2024
Impact of Treatment Response on Risk of Serious Infections in Patients With Crohn's Disease: Secondary Analysis of the PYRAMID RegistryDhruv Ahuja, Jiyu Luo, Yuchen Qi, et al.
Digestive Diseases and Sciences|March 15, 2020
Hypoalbuminemia and Bandemia Predict Failure of Infliximab Rescue Therapy in Acute Severe Ulcerative ColitisGaurav Syal, Lori Robbins, Amir Kashani, et al.
The American Journal of Gastroenterology|March 12, 2025
IL-23p19 Antagonists vs Ustekinumab for Treatment of Crohn's Disease: A Meta-Analysis of Randomized Controlled TrialsClaudia Dziegielewski, Yuhong Yuan, Christopher Ma, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 28, 2024
Differential Efficacy of Advanced Therapies in Inducing Remission in Ulcerative Colitis Based on Prior Exposure to TNF AntagonistsHan Hee Lee, Virginia Solitano, Sujay Singh, et al.
Gastroenterology|November 22, 2025
AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn's DiseaseFrank I Scott, Ashwin N Ananthakrishnan, Benjamin Click, et al.
Pageof 6